TLGT - Teligent, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
4.22
+0.21 (+5.24%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close4.01
Open4.01
Bid4.11 x 1000
Ask4.30 x 2000
Day's range3.97 - 4.26
52-week range2.43 - 8.67
Volume544,117
Avg. volume664,747
Market cap225.824M
Beta0.53
PE ratio (TTM)N/A
EPS (TTM)-0.39
Earnings date28 Jul 2017 - 31 Jul 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.30
Trade prices are not sourced from all markets
  • AGN or TLGT: Which Is the Better Value Stock Right Now?
    Zacks2 days ago

    AGN or TLGT: Which Is the Better Value Stock Right Now?

    AGN vs. TLGT: Which Stock Is the Better Value Option?

  • AGN vs. TLGT: Which Stock Should Value Investors Buy Now?
    Zacks2 days ago

    AGN vs. TLGT: Which Stock Should Value Investors Buy Now?

    AGN vs. TLGT: Which Stock Is the Better Value Option?

  • Why Teligent Rose ~10.4% Yesterday
    Market Realistlast month

    Why Teligent Rose ~10.4% Yesterday

    On June 14, Teligent (TLGT) stock rose ~10.4% on the news of the FDA approval of its diflorasone diacetate ointment 0.05%. Investors were pleased with the news, and TLGT stock soared more than 10%. Teligent plans to launch the product in the third quarter of 2018.

  • Associated Press2 months ago

    Teligent: 1Q Earnings Snapshot

    The Buena, New Jersey-based company said it had a loss of 9 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 4 cents per share. The specialty generic pharmaceutical ...

  • Associated Press4 months ago

    Teligent reports 4Q loss

    The Buena, New Jersey-based company said it had a loss of 11 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 6 cents per share. The specialty generic pharmaceutical ...

  • Generic Drugmakers to Dump as Teva's Woes Continue in 2018
    Zacks5 months ago

    Generic Drugmakers to Dump as Teva's Woes Continue in 2018

    The generic industry is facing several challenges pulling down several companies including Teva (TEVA).

  • Here's Why Teligent Stock Was Cut Nearly in Half Today
    Motley Fool8 months ago

    Here's Why Teligent Stock Was Cut Nearly in Half Today

    Third-quarter 2017 results show the company's high-growth business model is not without risks.

  • Associated Press8 months ago

    Teligent reports 3Q loss

    On a per-share basis, the Buena, New Jersey-based company said it had a loss of 12 cents. Losses, adjusted for non-recurring costs and amortization costs, came to 8 cents per share. The results did not ...

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes